Forecast: Pharmaceutical Preparations Production Value in Poland

The production value of pharmaceutical preparations in Poland has exhibited significant fluctuation from 2013 to 2023. Initially, there was intermittent growth with notable increases in 2015 and 2017. However, from 2018 onwards, a consistent downward trend was observed, with significant year-on-year declines particularly evident from 2020 to 2023. The production value in 2023 stood at 1.99 billion Euros, representing a substantial decline, especially compared to previous peaks.

Key trends over the last two years indicate a steep decline in production value, with a year-on-year decrease of 10.52% in 2023. This continues from a 9.59% decline in 2022. The CAGR for the last five years stands at -6.98%, reflecting persistent negative growth. Forecast data suggest that this downward trend will continue, with the production value expected to halve by 2028, leading to a forecast 5-year CAGR of -13.45%.

Future trends to watch for include potential market consolidation, shifts in regulatory policies, and innovation in pharmaceutical technologies, which may alter the current trajectory. Monitoring economic policies and healthcare reforms will also be crucial in understanding future market dynamics.

Latest reports

 US Pharmaceuticals Market Report- Q4 2024

US Pharmaceuticals Market Report- Q4 2024

In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...

 Japan Pharmaceuticals Market Report- Q4 2024

Japan Pharmaceuticals Market Report- Q4 2024

The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...

 Germany Pharmaceuticals Market Report- Q4 2024

Germany Pharmaceuticals Market Report- Q4 2024

The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...

 India Pharmaceuticals Market Report- Q4 2024

India Pharmaceuticals Market Report- Q4 2024

The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...

 UK Pharmaceuticals Market Report- Q4 2024

UK Pharmaceuticals Market Report- Q4 2024

The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...

 France Pharmaceuticals Market Report- Q4 2024

France Pharmaceuticals Market Report- Q4 2024

The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...

 Canada Pharmaceuticals Market Report- Q4 2024

Canada Pharmaceuticals Market Report- Q4 2024

In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...

 Brazil Pharmaceuticals Market Report- Q4 2024

Brazil Pharmaceuticals Market Report- Q4 2024

The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...

 Italy Pharmaceuticals Market Report- Q4 2024

Italy Pharmaceuticals Market Report- Q4 2024

The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...

 South Korea Pharmaceuticals Market Report- Q1 2025

South Korea Pharmaceuticals Market Report- Q1 2025

The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...

Top Countries about Pharmaceutical